USD 40.69 billion
Peptide Therapeutics Market Size, Share, Growth Analysis, By Type (Generic, Innovative), By Type of Manufacturers (In-house, Outsourced), By Synthesis Technology, By Route of Administration, By Application, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2072 |
Region:
Global |
Published Date: February, 2024
Pages:
213
|Tables:
152
|Figures:
78
Peptide Therapeutics Market Insights
Peptide Therapeutics Market size was valued at USD 43.11 Billion in 2023 and is poised to grow from USD 45.67 Billion in 2024 to USD 72.46 Billion by 2032, growing at a CAGR of 5.94% during the forecast period (2025-2032).
Growing prevalence of chronic diseases around the world and increasing investments in drug discovery and development are projected to drive peptide therapeutics demand in the future. Rising awareness regarding the low toxicity of peptide therapeutics among patients and medical professionals will also benefit peptide therapeutics market growth in the future. Advancements in peptide synthesis are also expected to play a crucial role in governing sales of peptide therapeutics over the coming years.
High adoption of targeted therapies for the treatment of several indications owing to their high specificity in treatment will also favor the demand for peptide therapeutics. Surging incidence of cancer is also expected to benefit the market growth as use of peptide therapeutics in treatment of cancer picks up pace. Supportive government funding to advance biopharmaceutical research will also create new opportunities for peptide therapeutics companies. However, limited oral bioavailability, high costs of production, and competition from biologics and other drugs are estimated to be key restraints for peptide therapeutics market growth in the long run.
US Peptide Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Innovative
Fastest Growth
Innovative
Growth Rate
5.94% CAGR
Global Peptide Therapeutics Market ($ Bn)
Country Share for Asia Pacific Region (%)
To get more reports on the above market click here to Buy The Report
Peptide Therapeutics Market Segmental Analysis
Peptide Therapeutics Market is segmented by Type, Type of Manufacturers, Synthesis Technology, Route of Administration, Application and region. Based on Type, the market is segmented into Generic, Innovative. Based on Type of Manufacturers, the market is segmented into In-house, Outsourced. Based on Synthesis Technology, the market is segmented into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology. Based on Route of Administration, the market is segmented into Parenteral, Oral, Pulmonary, Mucosal, Others. Based on Application, the market is segmented into Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Gastrointestinal Disorders, Infectious Diseases, Pain, Dermatological Disorders, Neurological Disorders, Renal Disorders, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Peptide Therapeutics Market Analysis by Application
Most peptide therapeutics are projected to be used for the treatment of metabolic disorders. Growing approval of the use of peptide therapeutics for the treatment of metabolic diseases and increasing investments in the development of the same are helping this segment maintain its high peptide therapeutics market share. Surge in prevalence of metabolic disorders and rising availability of peptides to help with the treatment of the same are also expected to further aid the dominance of this segment in the future.
Surging incidence of cancer among people around the world makes it the fastest-growing segment for peptide therapeutics industry. Growing demand for novel treatments for cancer and rising investments in oncology research are also expected to create lucrative opportunities for peptide therapeutics providers in the long run.
Peptide Therapeutics Market Analysis by Type
Innovative peptide therapeutics are projected to account for a substantial peptide therapeutics market share. Rising investments in medical R&D and growing demand for novel treatments are helping this segment maintain its high market share. Use of advanced peptides and growing advancements in synthesis are making helping the creation of innovative peptide therapeutics. However, high costs of innovative peptide therapeutics could hurt the market share of this segment going forward.
Meanwhile, the demand for generic peptide therapeutics is projected to surge at an impressive pace across the study period and beyond. Growing demand for affordable therapeutics and drugs around the world is slated to help boost sales of generic peptide therapeutics. High emphasis on healthcare cost reduction and patent expiry of novel drugs and innovative peptide therapeutics are also predicted to help bolster the peptide therapeutics market share of this segment in the future.
Global Peptide Therapeutics Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Peptide Therapeutics Market Regional Insights
North America is estimated to secure the top spot when it comes to the peptide therapeutics market. Increasing incidence of chronic diseases and high investments in medical research are forecasted to be the key factors contributing to the dominance of this region. Presence of key pharmaceutical manufacturers, rising awareness regarding benefits of peptide therapeutics, and supportive government funding to boost medical R&D are also expected to bolster sales of peptide therapeutics in this region. The United States is projected to lead the demand for peptide therapeutics in North America followed by Canada.
Rising investments in healthcare infrastructure development and growing demand for novel treatments are slated to make the Asia Pacific region the fastest growing market for peptide therapeutics companies. The rowing popularity of targeted therapies, use of advanced healthcare technologies, and presence of key contract manufacturing organizations in this region are expected to help boost sales of peptide therapeutics in this region. India, China, Japan, and South Korea are projected to be the most opportune countries for peptide therapeutics providers in this region.
Global Peptide Therapeutics Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Peptide Therapeutics Market Dynamics
Peptide Therapeutics Market Drivers
Rising Incidence of Chronic Diseases
- Poor lifestyle choices and growing adoption of unhealthy habits have lead to a major surge in incidence of chronic diseases around the world. As prevalence of diabetes, cancer, and other diseases rises, so does the need for better treatment for the same also rises. Low toxicity of peptide therapeutics makes them a preferred choice for treatment for multiple chronic diseases.
Rising Use of Targeted Therapies
- Healthcare professionals around the world are focusing on using targeted therapies to treat and manage various types of disease indications as prevalence of chronic diseases rises. Peptide therapeutics are highly efficient in targeting specific cell receptors, which makes them a mainstay in targeted therapy use.
Peptide Therapeutics Market Restraints
Limited Oral Bioavailability
- Peptides can be easily digested if consumed orally and this is a key issue that is limiting the scope of administration of peptide therapeutics orally. This leads to peptide therapeutics being administered through invasive procedures such as injections, which not many people opt for as most prefer non-invasive treatments.
High Production Costs
- Manufacturing and preparing peptide therapeutics is a complex task that requires high precision. Moreover, the complexity of peptide structures also adds up to the complexity of manufacturing. All of these factors result in high costs of production for peptide therapeutics and thereby impede peptide therapeutics market growth potential as well.
Request Free Customization of this report to help us to meet your business objectives.
Peptide Therapeutics Market Competitive Landscape
Peptide therapeutics providers around the world are estimated to focus on research to maximize their business potential and stay competitive. Developing new therapeutics for different diseases indications will also be a preferred strategy for new as well as leading peptide therapeutics companies. Taking advantage of supportive government initatives to promote medical R&D will also create new opportunities in the future.
Peptide Therapeutics Market Top Player’s Company Profiles
- Eli Lilly and Company
- Amgen Inc.
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Novo Nordisk A/S
- Takeda Pharmaceutical Company Limited
- AstraZeneca PLC
- Sanofi SA
- GlaxoSmithKline PLC
- Novartis AG
- Zealand Pharma A/S
- AmbioPharm Inc.
- Bachem Holding AG
- PolyPeptide Group
- Circle Pharma, Inc.
- PeptiDream Inc.
- Apitope Technology Ltd.
- Ever Neuro Pharma GmbH
- Teva Pharmaceuticals Industries Ltd.
- Arch Biopartners Inc.
Peptide Therapeutics Market Recent Developments
- In August 2024, cGMP peptide manufacturing capacity was completed at a pharmaceutical manufacturing facility in Yangzhou, China. The move was triggered by the investment from Aurisco Pharmaceutical to expand the production of Aurisco’s generic GLP-1 peptides.
- In February 2024, a new company entered the peptide therapeutics market with around USD 28 million in funding. Orbis Medicines was launched with the intention of developing macrocyclic peptides for a wide variety of disease indications. Novo Holdings and Forbion led the financial seed raise round for Orbis.
- Back in December 2023, SynCrest Inc. In collaboration with Otsuka Chemical Co., Ltd., and Yokogawa Electric Corp. announced the launch of its CDRMO services for peptide therapeutics. Through this announcement, the company made its services accessible to pharmaceutical organizations working in South America, Japan, North America, and Europe.
Peptide Therapeutics Key Market Trends
- Development of Oral Peptide therapeutics: Peptide therapeutics companies can focus on the development of oral peptide therapeutics which are currently not widely available in the market. Heavy investments in research would be required to develop peptide therapeutics that can be administered orally but will pay of big time for any company who dives into this peptide therapeutics market trend going forward.
- Development of Peptide Vaccines: Peptide therapeutics providers can also explore the potential of developing peptide vaccines, as demand for vaccines rises globally. Peptide-based vaccines can be used for infectious diseases, cancer, and autoimmune disorders, due to their specificity and safety profile.
Peptide Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global peptide therapeutics market analysis, peptide medicine research has advanced significantly in recent years due to advances in production, modification, and analytical technologies. The fundamental limitations of peptides have been removed, which has allowed for market expansion. Due to the adoption of a modern and unhealthy lifestyle, there is a clear rising trend in metabolic illnesses including diabetes and obesity as well as an increase in cardiovascular diseases and cancer. The market opportunity for peptide therapies is therefore driven by the aforementioned factors.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 40.69 billion |
| Market size value in 2031 | USD 68.4 billion |
| Growth Rate | 5.94% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Peptide Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Peptide Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Peptide Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peptide Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peptide Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peptide Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
